Sign in

CIK 0001422143 · Non-accelerated filer<br>Smaller reporting company

Kura Oncology, Inc.

Sign in to watch
Ticker
KURA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
611547851
Phone
(858) 500-8800
Business address
4930 DIRECTORS PLACE, SUITE 500, SAN DIEGO, CA, 92121
Former names
ZETA ACQUISITION CORP III
  1. 144 Insider Sale of Securities
  2. 4 Planned sale Chief Operating Officer sold 6,902 shares at $11.18 ($77,143)
  3. 144 Insider Sale of Securities
  4. 144 Insider Sale of Securities
  5. 144 Insider Sale of Securities
  6. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  7. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  8. 8-K Event Other events
  9. S-8 Other Securities Offered to Employees in Benefit Plans
  10. 10-Q Report Quarterly Report
  11. 8-K Event Results of operations
  12. 8-K Event Other events
  13. 8-K Event Other events
  14. 144 Insider Sale of Securities
  15. 144 Insider Sale of Securities
  16. 144 Insider Sale of Securities
  17. 144 Insider Sale of Securities
  18. 144 Insider Sale of Securities
  19. 144 Insider Sale of Securities
  20. 4 Open-market sale Chief Commercial Officer sold 8,891 shares at $8.94 ($79,505)

Page 6 of 41 · 809 filings